Schedule 13G ownership disclosure
MAINZ BIOMED N V
Ordinary Shares, nominal value of 0.01 per share · CUSIP: N5436L119
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 324,821.00 · Class: 9.99%
- Steven Boyd
Shares: 324,821.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-002289
- Form type
- SCHEDULE 13G/A
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership